Cross Ctry Healthcare Inc Financials
Cross Ctry Healthcare Inc (CCRN) reported $1.0B in revenue over the twelve months to Mar 31, 2026, down 20.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue contraction is exposing a cost structure that has not adjusted, while working-capital releases keep cash flow positive.
Revenue contraction brought revenue to$1.05B from its earlier peak, while operating margin reached-8.0% in the latest period; that pairing points to operating deleverage, not merely lower volume. Positive operating cash flow of$48M despite net income of-$95M means reported cash generation is being supported by cash-conversion mechanics outside current-period earnings.
The balance sheet is contracting alongside operations: total assets reached
Accounts receivable fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cross Ctry Healthcare Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cross Ctry Healthcare Inc has an operating margin of -8.0%, meaning the company loses $8 on every $100 of revenue. This results in a profitability score of 26/100. This is down from -1.3% the prior year.
Cross Ctry Healthcare Inc's revenue declined 21.6% year-over-year, from $1.3B to $1.1B. This contraction results in a growth score of 3/100.
Cross Ctry Healthcare Inc has a moderate D/E ratio of 0.39. This balance of debt and equity financing earns a leverage score of 64/100.
With a current ratio of 3.78, Cross Ctry Healthcare Inc holds $3.78 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.
Cross Ctry Healthcare Inc has a free cash flow margin of 3.8%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.
Cross Ctry Healthcare Inc posts a -29.4% return on equity (ROE), meaning it loses $29 for every $100 of shareholders' equity. This results in a returns score of 22/100. This is down from -3.5% the prior year.
Cross Ctry Healthcare Inc scores 4.73, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cross Ctry Healthcare Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Cross Ctry Healthcare Inc reported a net loss of $94.9M while generating $48.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Cross Ctry Healthcare Inc reported an operating loss of $84.4M against $2.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Cross Ctry Healthcare Inc generated $1.1B in revenue in fiscal year 2025. This represents a decrease of 21.6% from the prior year.
Cross Ctry Healthcare Inc's EBITDA was -$67.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 5165.2% from the prior year.
Cross Ctry Healthcare Inc reported -$94.9M in net income in fiscal year 2025. This represents a decrease of 551.6% from the prior year.
Cross Ctry Healthcare Inc earned -$2.93 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 565.9% from the prior year.
Cash & Balance Sheet
Cross Ctry Healthcare Inc generated $40.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 64.0% from the prior year.
Cross Ctry Healthcare Inc held $108.7M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Cross Ctry Healthcare Inc's operating margin was -8.0% in fiscal year 2025, reflecting core business profitability. This is down 6.8 percentage points from the prior year.
Cross Ctry Healthcare Inc's net profit margin was -9.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 7.9 percentage points from the prior year.
Cross Ctry Healthcare Inc's ROE was -29.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 25.9 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Cross Ctry Healthcare Inc spent $6.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 81.7% from the prior year.
Cross Ctry Healthcare Inc invested $8.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 6.3% from the prior year.
Not reported for fiscal year 2025.
CCRN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $241.1M+1.8% | $236.8M-5.3% | $250.1M-8.8% | $274.1M-6.6% | $293.4M-5.3% | $309.9M-1.6% | $315.1M-7.3% | $339.8M |
| Gross Profit | N/A | $48.0M-5.8% | $50.9M-9.1% | $56.0M-4.5% | $58.7M-5.4% | $62.0M-3.4% | $64.2M-9.4% | $70.8M |
| SG&A Expenses | $45.8M | N/A | $46.9M-6.3% | $50.0M-4.6% | $52.5M | N/A | $54.3M-9.9% | $60.3M |
| Operating Income | -$4.2M | N/A | -$6.0M-1.9% | -$5.9M-499.7% | -$977K | N/A | $2.9M+114.9% | -$19.2M |
| Interest Expense | $567K | N/A | $556K+1.3% | $549K+1.1% | $543K | N/A | $550K-3.2% | $568K |
| Income Tax | $532K | N/A | -$863K-192.8% | $930K+327.4% | -$409K | N/A | $834K+123.7% | -$3.5M |
| Net Income | -$4.3M+94.9% | -$82.9M-1637.1% | -$4.8M+28.3% | -$6.7M-1259.0% | -$490K+86.9% | -$3.8M-246.9% | $2.6M+115.9% | -$16.1M |
| EPS (Diluted) | -$0.14+94.5% | -$2.56-1606.7% | -$0.15+25.0% | -$0.20-900.0% | -$0.02+83.3% | -$0.12-250.0% | $0.08+117.0% | -$0.47 |
Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses.
CCRN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $451.1M+0.5% | $449.0M-16.6% | $538.2M-2.8% | $553.8M-3.9% | $576.2M-2.2% | $589.3M-1.4% | $597.4M-0.9% | $602.9M |
| Current Assets | $298.3M+1.6% | $293.6M-0.5% | $295.1M-4.5% | $309.1M-5.0% | $325.2M-2.9% | $335.0M-0.5% | $336.6M-0.3% | $337.8M |
| Cash & Equivalents | $105.6M-2.9% | $108.7M+9.7% | $99.1M+22.1% | $81.2M+0.6% | $80.7M-1.1% | $81.6M+27.5% | $64.0M-8.0% | $69.6M |
| Accounts Receivable | $176.6M+5.4% | $167.5M-7.0% | $180.2M-10.7% | $201.7M-8.2% | $219.8M-1.5% | $223.2M-8.9% | $245.0M+1.1% | $242.3M |
| Goodwill | $63.8M0.0% | $63.8M-52.8% | $135.1M0.0% | $135.1M0.0% | $135.1M0.0% | $135.1M-0.3% | $135.4M0.0% | $135.4M |
| Total Liabilities | $138.3M+9.6% | $126.1M-3.0% | $130.1M-8.1% | $141.6M-10.4% | $158.0M-7.2% | $170.3M-1.4% | $172.7M+5.4% | $163.8M |
| Current Liabilities | $90.6M+16.5% | $77.8M-9.1% | $85.5M-11.0% | $96.2M-11.8% | $109.0M-9.4% | $120.4M-0.2% | $120.7M+9.6% | $110.1M |
| Total Equity | $312.8M-3.1% | $322.8M-20.9% | $408.1M-1.0% | $412.2M-1.4% | $418.2M-0.2% | $419.0M-1.3% | $424.7M-2.0% | $433.3M |
| Retained Earnings | $118.9M-3.5% | $123.2M-40.2% | $206.1M-2.3% | $210.9M-3.1% | $217.6M-0.2% | $218.1M-1.7% | $221.8M-1.4% | $225.0M |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
CCRN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.8M-73.9% | $18.2M-9.3% | $20.1M+377.0% | $4.2M-25.8% | $5.7M-76.6% | $24.2M+224.4% | $7.5M-90.9% | $82.4M |
| Capital Expenditures | $1.5M-31.1% | $2.1M-3.4% | $2.2M+11.4% | $2.0M+4.3% | $1.9M-25.5% | $2.5M+125.2% | $1.1M-60.5% | $2.8M |
| Free Cash Flow | $3.3M-79.5% | $16.1M-10.0% | $17.9M+696.6% | $2.3M-40.7% | $3.8M-82.5% | $21.7M+242.0% | $6.3M-92.0% | $79.6M |
| Investing Cash Flow | -$1.5M+31.1% | -$2.1M+3.4% | -$2.2M-11.4% | -$2.0M-4.3% | -$1.9M+25.5% | -$2.5M-125.2% | -$1.1M+60.5% | -$2.8M |
| Financing Cash Flow | -$6.5M+1.0% | -$6.5M-108550.0% | -$6K+99.7% | -$1.8M+62.8% | -$4.7M-15.9% | -$4.1M+65.8% | -$11.9M+21.5% | -$15.2M |
| Share Buybacks | $5.9M-10.0% | $6.5M | $0 | $0-100.0% | $314K-92.3% | $4.1M-65.8% | $11.9M-20.2% | $14.9M |
Not reported in any period shown, so not listed: Dividends Paid.
CCRN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 20.3%-0.1pp | 20.4%-0.1pp | 20.4%+0.4pp | 20.0%0.0pp | 20.0%-0.4pp | 20.4%-0.5pp | 20.8% |
| Operating Margin | -1.7% | N/A | -2.4%-0.3pp | -2.1%-1.8pp | -0.3% | N/A | 0.9%+6.6pp | -5.7% |
| Net Margin | -1.8%+33.3pp | -35.0%-33.1pp | -1.9%+0.5pp | -2.4%-2.3pp | -0.2%+1.0pp | -1.2%-2.0pp | 0.8%+5.5pp | -4.7% |
| Return on Equity | -1.4%+24.3pp | -25.7%-24.5pp | -1.2%+0.4pp | -1.6%-1.5pp | -0.1%+0.8pp | -0.9%-1.5pp | 0.6%+4.3pp | -3.7% |
| Return on Assets | -0.9%+17.5pp | -18.5%-17.6pp | -0.9%+0.3pp | -1.2%-1.1pp | -0.1%+0.6pp | -0.6%-1.1pp | 0.4%+3.1pp | -2.7% |
| Current Ratio | 3.29-0.5x | 3.78+0.3x | 3.45+0.2x | 3.21+0.2x | 2.98+0.2x | 2.780.0x | 2.79-0.3x | 3.07 |
| Debt-to-Equity | 0.44+0.1x | 0.39+0.1x | 0.320.0x | 0.340.0x | 0.380.0x | 0.410.0x | 0.410.0x | 0.38 |
| FCF Margin | 1.4%-5.4pp | 6.8%-0.4pp | 7.2%+6.3pp | 0.8%-0.5pp | 1.3%-5.7pp | 7.0%+5.0pp | 2.0%-21.4pp | 23.4% |
Similar Companies
Where Cross Ctry Healthcare Inc Ranks
Frequently Asked Questions
What is Cross Ctry Healthcare Inc's annual revenue?
Cross Ctry Healthcare Inc (CCRN) reported $1.1B in total revenue for fiscal year 2025. This represents a -21.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cross Ctry Healthcare Inc's revenue growing?
Cross Ctry Healthcare Inc (CCRN) revenue declined by 21.6% year-over-year, from $1.3B to $1.1B in fiscal year 2025.
Is Cross Ctry Healthcare Inc profitable?
No, Cross Ctry Healthcare Inc (CCRN) reported a net income of -$94.9M in fiscal year 2025, with a net profit margin of -9.0%.
What is Cross Ctry Healthcare Inc's EBITDA?
Cross Ctry Healthcare Inc (CCRN) had EBITDA of -$67.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Cross Ctry Healthcare Inc's operating margin?
Cross Ctry Healthcare Inc (CCRN) had an operating margin of -8.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Cross Ctry Healthcare Inc's net profit margin?
Cross Ctry Healthcare Inc (CCRN) had a net profit margin of -9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Cross Ctry Healthcare Inc's return on equity (ROE)?
Cross Ctry Healthcare Inc (CCRN) has a return on equity of -29.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cross Ctry Healthcare Inc's free cash flow?
Cross Ctry Healthcare Inc (CCRN) generated $40.1M in free cash flow during fiscal year 2025. This represents a -64.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cross Ctry Healthcare Inc's operating cash flow?
Cross Ctry Healthcare Inc (CCRN) generated $48.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cross Ctry Healthcare Inc's total assets?
Cross Ctry Healthcare Inc (CCRN) had $449.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cross Ctry Healthcare Inc's capital expenditures?
Cross Ctry Healthcare Inc (CCRN) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Cross Ctry Healthcare Inc's current ratio?
Cross Ctry Healthcare Inc (CCRN) had a current ratio of 3.78 as of fiscal year 2025, which is generally considered healthy.
What is Cross Ctry Healthcare Inc's debt-to-equity ratio?
Cross Ctry Healthcare Inc (CCRN) had a debt-to-equity ratio of 0.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cross Ctry Healthcare Inc's return on assets (ROA)?
Cross Ctry Healthcare Inc (CCRN) had a return on assets of -21.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cross Ctry Healthcare Inc's Altman Z-Score?
Cross Ctry Healthcare Inc (CCRN) has an Altman Z-Score of 4.73, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cross Ctry Healthcare Inc's Piotroski F-Score?
Cross Ctry Healthcare Inc (CCRN) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cross Ctry Healthcare Inc's earnings high quality?
Cross Ctry Healthcare Inc (CCRN) reported a net loss of $94.9M while generating $48.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cross Ctry Healthcare Inc cover its interest payments?
Cross Ctry Healthcare Inc (CCRN) reported an operating loss of $84.4M against $2.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Cross Ctry Healthcare Inc?
Cross Ctry Healthcare Inc (CCRN) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.